Weiss Multi-Strategy Advisers’s Aratana Therapeutics, Inc. PETX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-175,000
| Closed | -$630K | – | 620 |
|
|
2019
Q1 | $630K | Buy |
175,000
+25,000
| +17% | +$90K | 0.02% | 354 |
|
|
2018
Q4 | $920K | Sell |
150,000
-5,000
| -3% | -$30.7K | 0.04% | 257 |
|
|
2018
Q3 | $905K | Buy |
155,000
+20,000
| +15% | +$117K | 0.02% | 325 |
|
|
2018
Q2 | $574K | Buy |
135,000
+35,000
| +35% | +$149K | 0.01% | 380 |
|
|
2018
Q1 | $441K | Buy |
100,000
+40,000
| +67% | +$176K | 0.01% | 389 |
|
|
2017
Q4 | $316K | Hold |
60,000
| – | – | 0.01% | 415 |
|
|
2017
Q3 | $368K | Hold |
60,000
| – | – | 0.01% | 374 |
|
|
2017
Q2 | $434K | Sell |
60,000
-5,000
| -8% | -$36.2K | 0.02% | 396 |
|
|
2017
Q1 | $345K | Buy |
65,000
+5,000
| +8% | +$26.5K | 0.01% | 417 |
|
|
2016
Q4 | $431K | Hold |
60,000
| – | – | 0.02% | 294 |
|
|
2016
Q3 | $562K | Sell |
60,000
-1,965
| -3% | -$18.4K | 0.03% | 276 |
|
|
2016
Q2 | $392K | Sell |
61,965
-29,035
| -32% | -$184K | 0.03% | 300 |
|
|
2016
Q1 | $502K | Hold |
91,000
| – | – | 0.02% | 340 |
|
|
2015
Q4 | $508K | Hold |
91,000
| – | – | 0.04% | 264 |
|
|
2015
Q3 | $770K | Buy |
91,000
+1,000
| +1% | +$8.46K | 0.03% | 240 |
|
|
2015
Q2 | $1.36M | Buy |
90,000
+23,500
| +35% | +$355K | 0.05% | 261 |
|
|
2015
Q1 | $1.07M | Buy |
66,500
+6,500
| +11% | +$104K | 0.05% | 286 |
|
|
2014
Q4 | $1.07M | Buy |
60,000
+30,000
| +100% | +$535K | 0.04% | 251 |
|
|
2014
Q3 | $301K | Buy |
30,000
+5,000
| +20% | +$50.2K | 0.01% | 408 |
|
|
2014
Q2 | $390K | Hold |
25,000
| – | – | 0.01% | 489 |
|
|
2014
Q1 | $464K | Buy |
+25,000
| New | +$464K | 0.01% | 628 |
|